WallStreetZenWallStreetZen

NYSE: CVS
Cvs Health Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CVS

Based on 17 analysts offering 12 month price targets for Cvs Health Corp

Min Forecast
$90.00+18.22%
Avg Forecast
$95.59+25.56%
Max Forecast
$102.00+33.98%

Should I buy or sell CVS stock?

Based on 17 analysts offering ratings for Cvs Health Corp.

Strong Buy
Strong Buy
12 analysts 70.59%
Buy
5 analysts 29.41%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CVS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CVS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CVS stock forecasts and price targets.

CVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-12
lockedlocked$00.00+00.00%2026-01-28
lockedlocked$00.00+00.00%2026-01-27
lockedlocked$00.00+00.00%2025-12-17Find Out Why
lockedlocked$00.00+00.00%2025-12-10Find Out Why
Piper Sandler
Bottom 5%
5
Strong BuyReiterates$101.00+32.67%2025-12-10
UBS
Top 19%
82
Strong BuyMaintains$97.00+27.41%2025-12-10Find out why
Barclays
Top 24%
77
Strong BuyMaintains$93.00+22.16%2025-12-10Find out why
Mizuho
Top 11%
90
BuyMaintains$95.00+24.79%2025-12-10
Morgan Stanley
Top 5%
96
Strong BuyMaintains$93.00+22.16%2025-12-10Find out why

1 of 2

Forecast return on equity

Is CVS forecast to generate an efficient return?

Company
17.57%
Industry
25.57%
Market
181.06%
CVS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CVS forecast to generate an efficient return on assets?

Company
5.21%
Industry
7.79%
CVS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CVS earnings per share forecast

What is CVS's earnings per share in the next 3 years based on estimates from 29 analysts?

Avg 1 year Forecast
$7.25+418.08%
Avg 2 year Forecast
$8.27+490.71%
Avg 3 year Forecast
$9.60+586.05%
CVS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CVS revenue forecast

What is CVS's revenue in the next 3 years based on estimates from 29 analysts?

Avg 1 year Forecast
$409.6B+1.88%
Avg 2 year Forecast
$428.3B+6.53%
Avg 3 year Forecast
$448.9B+11.64%
CVS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CVS earnings growth forecast

How is CVS forecast to perform vs Healthcare Plans companies and vs the US market?

Company
89.49%
Industry
31.22%
Market
36.33%
CVS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CVS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CVS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CVS revenue growth forecast

How is CVS forecast to perform vs Healthcare Plans companies and vs the US market?

Company
3.7%
Industry
3.71%
Market
13.46%
CVS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CVS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CVS vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
CVS$76.13$95.59+25.56%Strong Buy
CI$267.19$339.10+26.91%Strong Buy
ELV$291.63$377.25+29.36%Buy
HUM$165.43$222.00+34.20%Hold
CNC$34.45$42.46+23.24%Hold
View Top Healthcare Plan Stocks

Cvs Health Stock Forecast FAQ

Is Cvs Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NYSE: CVS) stock is to Strong Buy CVS stock.

Out of 17 analysts, 12 (70.59%) are recommending CVS as a Strong Buy, 5 (29.41%) are recommending CVS as a Buy, 0 (0%) are recommending CVS as a Hold, 0 (0%) are recommending CVS as a Sell, and 0 (0%) are recommending CVS as a Strong Sell.

If you're new to stock investing, here's how to buy Cvs Health stock.

What is CVS's earnings growth forecast for 2026-2028?

(NYSE: CVS) Cvs Health's forecast annual earnings growth rate of 89.49% is forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 31.22%, and it is also forecast to beat the US market's average forecast earnings growth rate of 36.33%.

Cvs Health's earnings in 2026 is $1,768,000,000.On average, 29 Wall Street analysts forecast CVS's earnings for 2026 to be $9,227,474,061, with the lowest CVS earnings forecast at $8,789,706,234, and the highest CVS earnings forecast at $9,885,079,960. On average, 28 Wall Street analysts forecast CVS's earnings for 2027 to be $10,521,058,270, with the lowest CVS earnings forecast at $9,611,300,139, and the highest CVS earnings forecast at $11,755,230,222.

In 2028, CVS is forecast to generate $12,219,205,597 in earnings, with the lowest earnings forecast at $10,940,379,036 and the highest earnings forecast at $14,159,709,131.

What is CVS's revenue growth forecast for 2026-2028?

(NYSE: CVS) Cvs Health's forecast annual revenue growth rate of 3.7% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 3.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.46%.

Cvs Health's revenue in 2026 is $402,067,000,000.On average, 29 Wall Street analysts forecast CVS's revenue for 2026 to be $521,121,823,414,997, with the lowest CVS revenue forecast at $493,892,690,033,608, and the highest CVS revenue forecast at $564,357,916,391,052. On average, 27 Wall Street analysts forecast CVS's revenue for 2027 to be $544,895,631,549,278, with the lowest CVS revenue forecast at $509,100,701,080,710, and the highest CVS revenue forecast at $590,906,416,853,736.

In 2028, CVS is forecast to generate $571,061,196,481,999 in revenue, with the lowest revenue forecast at $515,951,557,654,965 and the highest revenue forecast at $622,565,389,156,491.

What is CVS's forecast return on assets (ROA) for 2026-2029?

(NYSE: CVS) forecast ROA is 5.21%, which is lower than the forecast US Healthcare Plans industry average of 7.79%.

What is CVS's Price Target?

According to 17 Wall Street analysts that have issued a 1 year CVS price target, the average CVS price target is $95.59, with the highest CVS stock price forecast at $102.00 and the lowest CVS stock price forecast at $90.00.

On average, Wall Street analysts predict that Cvs Health's share price could reach $95.59 by Mar 12, 2027. The average Cvs Health stock price prediction forecasts a potential upside of 25.56% from the current CVS share price of $76.13.

What is CVS's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: CVS) Cvs Health's current Earnings Per Share (EPS) is $1.40. On average, analysts forecast that CVS's EPS will be $7.25 for 2026, with the lowest EPS forecast at $6.91, and the highest EPS forecast at $7.77. On average, analysts forecast that CVS's EPS will be $8.27 for 2027, with the lowest EPS forecast at $7.55, and the highest EPS forecast at $9.24. In 2028, CVS's EPS is forecast to hit $9.60 (min: $8.60, max: $11.13).

What is CVS's forecast return on equity (ROE) for 2026-2029?

(NYSE: CVS) forecast ROE is 17.57%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.